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Although ovarian follicle growth is under the influence of
many growth factors and hormones of which FSH remains one
of the most prominent regulators. Therefore, factors affecting
the sensitivity of ovarian follicles to FSH are also important
for follicle growth. The aim of the present study was to inves-
tigate whether anti-Mu¨llerian hormone (AMH) has an inhib-
itory effect on follicle growth by decreasing the sensitivity of
ovarian follicles to FSH. Furthermore, the combined action of
AMH and FSH on ovarian follicle development was examined.
Three different experiments were performed. Using an in
vitro follicle culture system it was shown that FSH-stimulated
preantral follicle growth is attenuated in the presence of
AMH. This observation was confirmed by an in vivo experi-
ment showing that in immature AMH-deficient females, more
follicles start to grow under the influence of exogenous FSH
than in their wild-type littermates. In a third experiment,
examination of the follicle population of 4-month-old wild-
type, FSH-, AMH-, and AMH-/FSH-deficient females re-
vealed that loss of FSH expression has no impact on the num-
ber of primordial and preantral follicles, but the loss of
inhibitory action of AMH on the recruitment of primordial
follicles in AMH-deficient mice is increased in the absence of
FSH. In conclusion, these studies show that AMH inhibits
FSH-stimulated follicle growth in the mouse, suggesting that
AMH is one of the factors determining the sensitivity of ovar-
ian follicles for FSH and that AMH is a dominant regulator of
early follicle growth. (Endocrinology 142: 4891–4899, 2001)
FSH IS REQUIRED FOR follicular growth from the largepreantral to the preovulatory stage. This is clearly
shown by the phenotype of FSH-deficient mice (1) or the
hypogonadal mouse model (2), which are infertile owing to
a block in folliculogenesis at the large preantral stage. Al-
though preantral follicle growth can occur in the absence of
FSH (1, 2), these follicles are able to respond to FSH. In
prepubertal rats, for example, treatment with GnRH antag-
onist for several days severely suppresses the gonadotropin
serum level and decreases the number of preantral follicles
(3), whereas treatment with FSH of intact, hypophysecto-
mized, or GnRH antagonist–treated juvenile rats, increased
preantral follicle growth (4).
During the estrous cycle, FSH sensitivity of ovarian folli-
cles seems to be important during the process of cyclic re-
cruitment (5), a process by which some large preantral and
small antral follicles are selected to grow to the preovulatory
follicle stage, and the nonselected follicles will undergo atre-
sia and disappear through apoptosis of the granulosa cells
(6). Experiments have shown that the level of serum FSH is
very important in this process. Elevated level of serum FSH
at estrus prevents some, but not all, follicles to become atretic
so that the former follicles are able to continue growth (7). In
this process of selection, the sensitivity of the individual
follicle to FSH appears to be of central importance. Studies
in bovines show that increased FSH sensitivity could be a
result of enhanced FSH receptor expression (8, 9).
The development of ovarian follicles, however, is not reg-
ulated by FSH alone. Other intraovarian factors, such as E
and growth factors, also are involved. Activins, inhibins, and
growth and differentiation factor 9 (GDF9), all members of
the TGF family of growth and differentiation factors, can
influence follicular development (10–12). Using anti-Mu¨lle-
rian hormone-deficient female mice, we showed recently that
anti-Mu¨llerian hormone (AMH), another member of the
TGF- family, inhibits the initiation of primordial follicle
growth (13). In the same study, we found that AMH-deficient
(AMHKO) female mice have an increased number of grow-
ing follicles in spite of a lower serum FSH level, compared
with their wild-type littermates. Together with previous
studies showing inhibitory effects of AMH on FSH-stimu-
lated actions of cultured granulosa cells (14–16), this would
suggest that AMH inhibits FSH-stimulated follicle growth.
This hypothesis was studied using three different experi-
mental approaches.
In an in vitro study, FSH-stimulated growth of preantral
follicles was studied in the presence or absence of AMH.
Subsequently, immature AMHKO females and their wild-
type littermates were treated for several days with GnRH
antagonist or with GnRH antagonist in combination with
FSH after which follicle growth was examined. Finally, fol-
Abbreviations: AMH, Anti-Mu¨llerian hormone; AMHKO, AMH-
deficient; FAKO, AMH-/FSH-deficient; FSHKO, FSH-deficient;
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licle growth was studied in 4-month-old AMH-/FSH-
deficient (FAKO) females, by comparing the follicle popu-
lation of the FAKO females with the follicle populations in
AMHKO, FSHKO, and wild-type females of the same age.
Materials and Methods
Animals
Different strains of mice were used in the three experiments described
in this paper. All strains were maintained on a C57Bl/6J background.
Animals were kept under standard animal housing conditions in ac-
cordance with the NIH Guidelines for the Care and Use of Experimental
Animals.
In Exp 1, F1 female offspring (B6CBA) from C57Bl/6J females and
CBA/J males from Harlan Winkelmann GmbH (Bohren, Germany) were
used to collect 21- to 23-d-old ovaries. The mice were anesthetized with
ether, and blood was collected by eye extraction. After clotting, blood
was centrifuged for 15 min at 4,000  g, and serum was collected and
stored at 20 C until it was used in the follicle culture medium. The
ovaries were used to isolate preantral follicles (17).
For Exp 2, wild-type and AMHKO female mice on a C57Bl/6J back-
ground were generated as described previously (13). Female mice of 25 d
of age were divided into four groups, each group containing six wild-
type and six AMHKO animals. The different treatment schedules are
shown in Fig. 2A. All injections were given twice daily at 0900 h and at
2100 h. The animals were killed by decapitation 12 h after receiving the
last injection. Group A was treated with saline from d 25 to d 28. Group
B received during the same period 200g GnRH antagonist per injection
(Org 30276; NV Organon, Oss, The Netherlands). Two additional groups
of mice received GnRH antagonist from d 25 to d 31. In addition to GnRH
antagonist, one of these two groups received saline (group C), and the
other group (group D) received 2.5 IU recombinant human FSH (Pur-
egon; NV Organon) per injection from d 29 to d 31.
Blood samples were collected from all animals directly after decap-
itation, kept overnight at 4 C, and centrifuged the following day at 3000
rpm for 15 min at 4 C. Serum samples were stored at20 C until assayed
for FSH, inhibin A, or inhibin B.
In Exp 3, female and male mice heterozygous for both FSH and
AMH null allele were used to obtain AMH-/FAKO females, FSH-
deficient (FSHKO), AMHKO, and wild-type female mice. Male
FSHKO mice that were used in the breedings were originally devel-
oped by Kumar et al. (1). FAKO females 4 months of age and their
wild-type, FSHKO and AMHKO littermates were killed by decapita-
tion at 1600 h. Wild-type and AMHKO females were killed on the day
of estrus because this day of the cycle can be recognized by female
behavior (13). Every group contained five animals.
In Exp 2 and 3, after decapitation ovaries were removed, weighed,
and fixed overnight in Bouin’s fluid. For histological examination of the
follicle population, the fixed ovaries were embedded in paraffin, and
after routine histological procedures, 8-m sections were mounted on
slides and stained with hematoxylin and eosin. In addition, uteri of these
mice were also weighed.
Determination of mouse AMH and FSH genotype
The genotype of the mice used in Exp 2 and 3, were determined by
PCR reactions. The AMH genotyping was described previously (13), but
a different method for isolation of genomic DNA was used (18).
Primers FSH-FOR (5-TTCAGCTTTCCCCAGAAGAG-3) and
FSH-REV (5-CTGCTGACAAAGAGTCTATG-3) were used to deter-
mine the presence of the FSH allele. Primer FSH-FOR anneals to
nucleotide sequence 32–51 located in exon 1 of the FSH gene (num-
bering according to GenBank sequence, accession number U12932),
whereas primer FSH-REV anneals to antisense sequence 278–259 lo-
cated in intron 1 of the FSH gene, resulting in a PCR product of 247 bp.
In animals carrying the FSH null allele, exons 1 and 2 and most of exon
3 are replaced by the PGK-Hprt expression cassette. Primer HPRT-FOR
(5-CCTGCTGGATTACAT-TAAAGCACT-3) and HPRT-REV (5-
GTCAAGGCA-TATCCAACAACAAA-3) were used to determine the
presence of the FSH null allele, i.e. the PGK-hprt expression cassette (1).
Primer HPRT-FOR anneals to the nucleotide sequence 318–341, whereas
primer HPRT-REV anneals to the antisense sequence 669–646 in the
PGK-hprt expression cassette, resulting in a PCR product of 352 bp.
For the PCR reactions, 25 pmol of all primers were used, and the PCR
reactions were executed as described previously (18). An annealing
temperature of 45 C for the wild-type allele and 55 C for the FSH
null allele was used. The products were electrophoresed on a 1.5%
agarose gel.
Ovarian histology and follicle counting
Serial 8-m sections of the ovaries were used for follicle counting,
which was performed as described previously (13). In Exp 2, both ova-
ries were used to determine the follicle population. With the exception
of primordial follicles (diameter  20 m), both nonatretic and atretic
follicles were included in the study. Atresia was defined according to the
description of Osman (6). The follicles were divided into four groups on
the basis of their mean diameter, which was determined by measuring
two perpendicular diameters in the section in which the nucleolus of the
oocyte was present: small preantral follicles (20–170m), large preantral
follicles (171–220 m), small antral follicles (221–310 m), and large
antral follicles (311–370 m).
In Exp 3 the right ovary of each animal was used for follicle counting
because we did not observe a difference in the composition of the follicle
populations of the right and left ovaries of the same female at the day
of estrus (unpublished observations). In this study, all follicles, both
nonatretic and atretic, were counted, including primordial follicles. The
follicles were divided into three groups on the basis of their mean
diameter (micrometers); primordial follicles (diameter  20 m), small
follicles (20–310 m), and large follicles (diameter  310 m). The
number of atretic oocytes was also determined (13).
AMH preparation
In the follicle culture experiment (Exp 1) recombinant rat AMH was
used. Human embryonic kidney 293 (HEK293) cells were stably trans-
fected with a cDNA encoding His-tagged rat AMH inserted in the
pRc/CMV expression vector. The AMH cDNA contained an optimized
cleavage site to ensure maximal amounts of cleaved mature AMH (19,
20). HEK293 cells were cultured in DMEM/F-12 (Life Technologies, Inc.,
Paisley, Scotland, UK) supplemented with 10% FCS, penicillin (400
IU/ml), streptomycin (0.4 mg/ml), and neomycin G418 (0.4 mg/ml). At
a cell confluence of about 80–90%, the medium was replaced by medium
without FCS. After 4 d the medium was collected.
His-tagged rat AMH was purified from the concentrated medium in
a three-step procedure. First, proteins with a molecular mass above 10
kDa (including AMH) were concentrated approximately 35-fold using
an Amicon filter system (Amicon/Millipore Corp., Bedford, MA). Next,
the concentrated medium was run over a Ni-column (NiNTA Superflow,
QIAGEN GmbH, Hilden, Germany) to separate the His-tagged AMH
from other proteins; subsequently the His-tagged rat AMH was eluted
from the Ni-column by imidazole (Sigma, St. Louis, MO). Finally, im-
idazole and AMH were separated using size chromatography (PD10
column, Amersham Pharmacia Biotech, Buckinghamshire, UK).
The amount of AMH was measured by ELISA, using the TMB per-
oxidase ElA substrate kit (Bio-Rad Laboratories, Inc., Hercules, CA). The
primary antibody, pentaHis monoclonal antibody (QIAGEN), was used
at 100 ng/ml. The secondary antibody, a goat-antimouse IgG peroxidase
conjugate (Sigma), was used in a 1:1000 dilution. The amount of AMH
was calibrated using the same standard preparation of His-tagged AMH
in every ELISA and was expressed in arbitrary units. The concentrated
supernatant of nontransfected HEK293 cells was used as control
medium.
The presence of AMH in the media used in the experiments was
investigated by Western blotting using a primary polyclonal antibody
to AMH (C-20, Santa Cruz Biotechnology, Inc., Santa Cruz, CA) in a
1:2000 dilution and a secondary peroxidase-conjugated mouse-anti-
goat/sheep antibody (Sigma) in a dilution of 1:10000 (data not shown).
The AMH preparations (800 U/ml) were shown to be bioactive using
a Mu¨llerian duct regression assay (19) (data not shown).
Follicle collection and follicle culture
For each culture, the ovaries of at least four animals were collected
aseptically and transferred into l-15 Leibovitz medium (Life Technol-
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ogies, Inc.) supplemented with 0.3% BSA (Sigma), 5 g/ml insulin
(Sigma), 2 mm glutamine (Life Technologies, Inc.), 10 g/ml transferrin
(Sigma), 50 g/ml l-ascorbic acid (Sigma), and 2 ng/ml selenium (Sig-
ma) at 37 C. Preantral follicles with a diameter of 135–210 m were
isolated by needle dissection (29-gauge 1⁄2 in.) and collected in MEM
medium (Life Technologies, Inc.) supplemented with 0.3% BSA, 5g/ml
insulin, 2 mm glutamine, 10g/ml transferrin, 50g/ml l-ascorbic acid,
and 2 ng/ml selenium. Follicles from different ovaries were pooled in
the collection medium and incubated in a humidified incubator, gassed
with 5% CO2 in air at 37 C.
Isolated follicles with a normal morphological appearance (i.e., a
central spherical oocyte, high density of granulosa cells, and a theca cell
layer enclosing the entire follicle) were divided into two groups with a
diameter of 135–165 m or 165–210 m and were subsequently indi-
vidually cultured in Millicel-CM culture plate inserts (Millipore Corp.)
with 250 l MEM culture medium supplemented with 5% immature
mouse serum in a humidified incubator gassed with 5% CO2 in air at 37
C. Half of the number of follicles was cultured in the presence of purified
rat AMH (800 U/ml). To induce follicle growth, 100 mIU/ml (10 ng/ml)
recombinant human FSH (Puregon; NV Organon) was added to the
culture medium after the first 24 h of culture. Culture medium was
exchanged on culture d 1 and 4. The diameter of the follicles was
measured on d 0, 1, 4, and 5 using 100 magnification and a calibrated
micrometer. In addition, on the same days, the survival rate of the
follicles was checked by evaluation of degeneration (blackening of the
follicle) and bursting (loss of oocyte). Three individual culture experi-
ments were performed.
Hormone analyses
In Exp 2 serum FSH was determined by RIA using rat FSH as ligand
and antibodies against ovine FSH (21). All results are expressed in terms
of NIDDK rat FSH RP-2. The intraassay variation was 7.2%, and all
samples were measured in one assay.
Inhibin A and B were measured using kits purchased from Serotec
Limited (Oxford, UK), using the human standards provided with the
kits. Suitability of the Serotec assays for measuring serum mouse inhibin
A and B dimers was investigated previously (22). The intraassay vari-
ation of the inhibin A assay was 9% and of inhibin B assay 15%. All
samples were measured in one assay.
Statistical analysis
Results are presented as the mean  sem. The data were evaluated
for statistical differences either by one-way ANOVA, followed by Dun-
can’s new multiple range test or by independent samples t test using
SPSS, Inc. 9 (SPSS, Inc., Chicago, IL) computer software. Serum inhibin
A and B levels were tested by a nonparametric test (Mann-Whitney test).
Differences were considered significant at P  0.05.
Results
Exp 1: Effect of AMH on FSH-stimulated preantral follicle
growth in vitro
To determine the effect of AMH on FSH-stimulated follicle
growth, preantral follicles with a mean diameter of 135–165
m (small preantral) and 165–210 m (large preantral) were
cultured in the presence of FSH alone or in the presence of
FSH and AMH.
In both follicle size groups, addition of exogenous AMH
caused inhibition of FSH-stimulated preantral follicle growth
in a time-dependent manner, indicated by the significantly
smaller diameter of follicles cultured in the presence of AMH
at d 4 and 5 of culture (Fig. 1). During the follicle culture, the
increase in diameter was mainly the result of an increase in
the number of granulosa cells (data not shown). The follicles
with the larger size at the start of the culture maintained a
larger diameter during the culture than the follicles with a
smaller starting size.
The survival rates of the follicles with a mean diameter
FIG. 1. Effect of AMH on FSH-stimulated preantral follicle growth in vitro. Preantral follicles with a diameter between 135 and 165 m (A)
or between 165 and 210 m (B) at d 0 of culture were cultured for 5 d in the presence of recombinant FSH (100 mIU/ml), with or without AMH
(800 U/ml). Follicle diameter was determined after 1, 4, and 5 d of culture. Data represent the mean  SEM (n ranging between 25 and 60).
a, Significant difference from follicles cultured in the absence of AMH (P  0.05). Note that error bars on d 1 and 2 in Fig. 1, A and B and on
d 3 in Fig. 1B are too small to be noticed.
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between 135 and 165m or 165 and 210m on d 4 and 5 were
83% and 56% or 97% and 93%, respectively, when cultured
with only FSH, and 68% and 55% or 96% and 87% in the
presence of both FSH and AMH. No statistically significant
difference was found for the survival rate between follicles
cultured in absence or presence of AMH (results not shown).
FIG. 2. Treatment of immature wild-type or AMHKO females with saline, GnRH antagonist, or GnRH antagonist in combination with
saline or FSH. A, Groups A and B were treated twice daily from d 25 to d 28, with saline or GnRH antagonist (200 g), respectively. The
animals were killed on d 29. Groups C and D were treated twice daily from d 25 to d 29 with GnRH antagonist, and from d 29 to d 31
with GnRH antagonist in combination with either saline or FSH (2.5 IU), respectively. The animals were killed on d 32. B, Number of
follicles in different treatment groups. Follicles were divided into four groups on basis of their diameter: small preantral follicles (20 –170
m), large preantral follicles (171–220 m), small antral follicles (221–310 m), and large antral follicles (311–370 m). Data represent
the mean  SEM (n  6). a, b, c, Significant difference from groups A, B, and C, respectively. *, Significant difference from wild-type females
within the same treatment group (P  0.05).
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Exp 2: FSH-stimulated follicle growth in AMHKO females
vs. wild-type females
The effect of AMH on FSH-stimulated follicle growth was
also determined in vivo. Therefore, immature wild-type and
AMHKO female mice were treated with GnRH antagonist to
induce low-serum FSH levels or with GnRH antagonist in
combination with FSH to obtain high levels of serum FSH.
The treatment schedule is shown in Fig. 2A.
Serum FSH level
Serum FSH level was measured in groups A, B, and C to
confirm the inhibitory effect of GnRH antagonist treatment
on endogenous serum FSH level and to compare this level
between wild-type and AMHKO females. The serum FSH
level of group D could not be determined because the anti-
body used in the RIA partially cross-reacts with the exoge-
nous FSH (23).
As expected, GnRH antagonist treatment resulted in a
significantly reduced serum FSH level in mice of both ge-
notypes (Table 1). Treatment with GnRH antagonist for 7 d
(group C) instead of 4 d (group B) did not significantly lower
the serum FSH level further. No significant difference in
serum FSH level was found between wild-type and AMHKO
females in the three treatment groups.
Uterine and ovarian weight
GnRH antagonist treatment suppressed both uterine and
ovarian weights in wild-type females but not in AMHKO
females (group B vs. group A), but FSH treatment increased
ovarian weight in both genotypes (group D vs. group C)
(Table 2). Within the treatment groups, a significant differ-
ence between the two genotypes was found only for the
ovarian weight and only when a low serum level of FSH was
present (groups B and C). In these groups the ovarian weight
was significantly higher in AMHKO females, compared with
the ovarian weight of their wild-type littermates.
Follicle counts
The total number of small preantral, large preantral, small
antral, and large antral follicles in both wild-type and
AMHKO females of the four different treatment groups were
determined and are shown in Fig. 2B.
In mice treated with saline from d 25 to d 28 (group A), the
follicles reached the large antral stage in both genotypes, and
no significant difference was found in the number of large
antral follicles between wild-type and AMHKO females. In
contrast, the number of large preantral and small antral fol-
licles was significantly higher in AMHKO females than in
wild-type females, whereas no significant difference was
found between the two genotypes for the number of small
preantral follicles. The decrease in serum FSH level in group
B resulted in the expected decrease in the number of antral
follicles in both genotypes. However, in AMHKO females a
large increase in the number of small preantral follicles was
found. An extended period of low-serum FSH level (group
C) caused a significant decrease in the number of large pre-
antral follicles in wild-type females, but this number was not
affected in AMHKO females. Notwithstanding the low se-
rum FSH level, the number of small antral follicles was
increased in AMHKO ovaries, but it was not affected in
wild-type females. Administration of FSH (group D) resulted
in the presence of large antral follicles and in an increase in
the number of small antral follicles in both genotypes. How-
ever, this increase in follicle number and size was more
pronounced in AMHKO mice.
Serum inhibin A and B levels
To determine whether the different treatments affected
serum inhibin A and B levels, serum levels of both hormones
were determined in all treatment groups.
In all groups, serum inhibin B level was higher than the
serum inhibin A level (Table 3). Treatment of the animals
with GnRH antagonist resulted in a decrease of both serum
inhibin A and B levels in both genotypes, although for in-
hibin B, this decrease was not significant in AMHKO mice.
Treatment with GnRH antagonist together with FSH resulted
in an increase of both inhibins.
Within all treatment groups, no significant difference in
the concentrations of both inhibins was found between wild-
type and AMHKO females, with the exception of the serum
TABLE 1. Serum FSH level in immature wild-type and AMHKO
females of different treatment groups
Treatment group
FSH (ng/ml)
Wild-type AMHKO
A (saline, d 25–28) 14.8  1.4 14.5  1.3
B (GnRH antagonist, d 25–28) 5.3  0.4a 5.4  1.1a
C (GnRH antagonist, d 25–31) 4.9  0.4 4.7  0.3
Values represent the mean  SEM (n  6). Animals were killed on
d 29 (groups A and B) or d 32 (group C).
a Significant difference from group A. Values were evaluated by
independent samples t test (P  0.05).
TABLE 2. Uterine and ovarian weights in wild-type and AMHKO female mice of different treatment groups
Treatment group
Ovarian weights (mg) Uterine weight (mg)
Wild-type AMHKO Wild-type AMHKO
A (saline, day 25–28) 4.5  0.2 4.5  0.4 13.2  0.4 14.4  2.1
B (GnRH antagonist, day 25–28) 3.2  0.3a 4.0  0.2b 11.9  0.3a 10.4  1.1
C (GnRH antagonist, day 25–31
 saline day 29–31)
2.3  0.2 3.6  0.2b 7.3  1.1 7.7  0.4
D (GnRH antagonist, day 25–31
 FSH, day 29–31)
4.5  0.3c 6.3  0.5c 8.2  0.7 7.6  0.7
Values represent the mean  SEM (n  6). Animals were killed on d 29 (groups A and B) or d 32 (groups C and D).
a,c Significant difference from groups A and C, respectively. b Significant difference from wild-type females. Values were evaluated by
independent-samples t test (P  0.05).
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inhibin B level in group B, which was slightly but signifi-
cantly higher in AMHKO females than in wild-type females.
Exp 3: Comparison of follicle growth in 4-month-old wild-
type, AMHKO and FSHKO, and FAKO females
The long-term effects of the absence of FSH and/or AMH
on the ovarian follicle population were investigated in vivo
in 4-month-old AMHKO, FSHKO, and FAKO mice.
Ovarian and uterine weight
In FSHKO mice ovarian weight was significantly de-
creased, but ovarian weight was increased in AMHKO mice,
compared with wild-type mice (Fig. 3A). In FAKO females,
the effect of the absence of AMH on ovarian weight was
further augmented, resulting in a slight but significantly
larger ovarian weight than in AMHKO females.
Absence of FSH caused a large decrease in uterine weight
in both FSHKO and FAKO females. This decrease, however,
was less pronounced in FAKO females (Fig. 3B). The absence
of only AMH did not affect uterine weight.
Ovarian morphology and follicle counts
The ovaries of all genotypes contained primordial, pre-
antral, small antral follicles, both nonatretic and atretic, and
atretic oocytes (Fig. 4, A–D). As expected, no large antral
follicles were found in FSHKO and FAKO females (Fig. 4,
C and D) because of the lack of FSH in these animals, but in
wild-type and AMHKO females, large follicles were absent
(Fig. 4, A and B) because at estrus these follicles have not yet
developed in mice with a normal estrous cycle. In wild-type
and AMHKO females, numerous fresh and old corpora lutea
were present (Fig. 4A). The ovaries of FSHKO females were
small owing to the lack of corpora lutea but contained fol-
licles that had progressed to the small antral stage (Fig. 4C).
In contrast, despite the lack of corpora lutea, ovaries of FAKO
females were large and contained many small preantral fol-
licles and small antral follicles (Fig. 4D). Furthermore, in
these ovaries many remnants of atretic follicles, also referred
to as atretic oocytes, were found (Fig. 4, E and F).
Figure 5 shows the effects of the absence of AMH and/or
FSH on the number of follicles in the different follicle classes.
Two-fold more nonatretic small follicles were found in the
absence of AMH (AMHKO), and this effect was strongly
increased in the additional absence of FSH (FSHKO) (Fig.
5B). Absence of FSH alone did not affect the number of
nonatretic small follicles. In all genotypes the changes in the
number of atretic small follicles and atretic oocytes were
similar to the changes in the number of nonatretic small
follicles (Fig. 5, C and D). The increase in the number of small
follicles in AMHKO and FAKO females is reflected by a
concomitant decrease in the number of primordial follicles
(Fig. 5A).
Discussion
Previously we have reported a quantitative analysis of the
follicle population in AMHKO females, which revealed that
AMH inhibited the recruitment of primordial follicles (13). In
the same study, more preantral and small antral follicles
were found in 4-month-old AMHKO females, compared
with wild-type females, despite a relatively low serum FSH
level, suggesting an effect of AMH on the sensitivity of grow-
ing follicles to FSH.
In the present study, we have studied the effect of AMH
on the FSH sensitivity of growing follicles more in detail. In
an in vitro follicle culture, we found that AMH inhibits FSH-
stimulated growth of mouse preantral follicles. However, in
another recent in vitro study (24), it was reported that AMH
enhanced FSH-stimulated growth of rat preantral follicles.
Two possible explanations for these contradictory results can
be put forward. Animal age (prepubertal vs. adult) could be
the cause, as was demonstrated by its influence on the effect
of activin A and TGF, like AMH members of the TGF
superfamily, on preantral follicle growth. Although activin A
stimulates growth of preantral follicles from immature mice
and not from adult mice, TGF stimulates growth of pre-
antral follicles derived from adult mice and not from imma-
ture mice (25, 26). Besides age, the developmental stage (e.g.,
number of granulosa cell layers) of the follicle can also be of
FIG. 3. Uterine and ovarian weight in 4-month-old wild-type,
AMHKO, FSHKO, and FAKO female mice. The combined weight of
both ovaries (A) and uterine weight (B) of wild-type, AMHKO,
FSHKO, and FAKO mice was determined. Data represent the
mean  SEM (n  4). a, b, c, d, Significant difference from wild-type,
AMHKO, FSHKO, and FAKO females, respectively (P  0.05).
TABLE 3. Serum inhibin A and B levels in immature wild-type and AMHKO females of different treatment groups
Treatment group
Inhibin A (ng/liter) Inhibin B (ng/liter)
Wild-type AMHKO Wild-type AMHKO
A (saline, d 25–28) 24  3 16  2 72  9 52  5
B (GnRH antagonist, d 25–28) 5a 5a 13  3a 30  6b
C (GnRH antagonist, d 25–31  saline, d 29–31) 5 5 10  2 14  2
D (GnRH antagonist, d 25–31  FSH, d 29–31) 59  19c 90  17c 266  85c 317  60c
Values represent the mean  SEM (n  6). Animals were killed on d 29 (groups A and B) or d 32 (groups C and D).
a,c Significant difference from groups A and C, respectively. b Significant difference from wild-type females. Values were evaluated by a
nonparametric test (Mann-Whitney test) (P  0.05).
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importance for the outcome of follicle culture experiments
because we found that growth of preantral follicles with a
diameter between 165 and 210 m derived from immature
mice was stimulated by GDF9, but smaller follicles (135–165
m) were unaffected by GDF9 (our unpublished results).
However, because in both our study and the study of McGee
et al. (24) preantral follicles with seven to nine layers of
granulosa cells from immature animals were used, a differ-
ence in age or developmental stage of the follicle cannot
readily be used to explain the difference in outcome. The
difference, however, could be the result of the use of mouse
serum in the culture medium in our study, suggesting that
the serum might contain factors influencing the action
of AMH.
The inhibitory effect of AMH on preantral follicle growth
in vitro is in agreement with previous studies in cultured
granulosa cells in which AMH was shown to negatively
influence FSH-induced processes, such as a decrease of the
aromatase activity and LH receptor number and the inhibi-
tion of progesterone synthesis (14–16). In addition, the result
of our in vitro study is in accordance with the result of our
in vivo study, in which follicle growth in the presence of high
or low serum FSH level was compared between wild-type
and AMHKO females. Growth of large preantral and small
antral follicles in AMHKO mice is less affected by longtime
exposure to low serum FSH level than in wild-type females
(group C vs. group B). Furthermore, in the presence of high
serum FSH level (group D), stimulation of follicle growth
was more pronounced in AMHKO females than in wild-type
females both in terms of numbers and of developmental
stage. These findings indicate that in the absence of AMH,
follicle growth is more sensitive to stimulation by FSH.
Both in vivo studies show that ovarian as well as uterine
weight can indicate changes in the follicle population. Al-
though in adult mice the ovarian weight is mainly deter-
mined by the mass of corpora lutea, as is clearly illustrated
by the 5-fold decrease in weight of the anovulatory ovaries
of FSHKO females, compared with the weight of wild-type
FIG. 4. Photomicrographs of ovarian
sections of 4-month-old wild-type,
AMHKO, FSHKO, and FAKO female
mice. A, B, Section of an ovary of a wild-
type mouse (A) and of an AMHKO
mouse (B). Follicles of different devel-
opmental stages are found in both ge-
notypes. In the wild-type ovary, a fresh
corpus luteum (CL) is present. Magni-
fication100. C, D, Section of an ovary
of an FSHKO mouse (C) and a FAKO
mouse (D). In both FSHKO and FAKO
females, follicle development occurs in
the small antral stage (SA). Magnifica-
tion,100. E, F, Sections of an ovary of
a FAKO mouse. Besides small antral
follicles, many remnants of atretic fol-
licles, also referred to as atretic oocytes
(AO), are found in the interstitium. In
some the degenerating oocyte can be
clearly seen (*). Magnification, 200.
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ovaries (1) (and present results), a previous study on
AMHKO females (13) and this study showed that a high
number of preantral follicles can significantly increase ovar-
ian weight. This observation is supported by the ovarian
weight of FAKO females, which is even further augmented
by the very high number of small follicles. Uterine weight can
be informative because the uterine epithelium is strongly
stimulated by E2 (27), produced mainly by large antral and
preovulatory follicles, although small antral and even pre-
antral follicles are able to produce small amounts of E as well.
In both in vivo studies, the changes in uterine weight clearly
support the histological observations in the ovaries.
In addition to the ovarian and uterine weights, serum
inhibin can also be used to register changes in the ovarian
follicle population. Inhibin A level was high in mice having
large antral follicles in their ovaries, but inhibin B level was
high in mice predominantly having preantral and small an-
tral follicles. These results are in accordance with follicle
culture experiments using immature mouse follicles show-
ing that inhibin A is predominantly produced by large antral
follicles and inhibin B by preantral and small antral follicles
(28).
Going back to the respective roles and interaction of AMH
and FSH in the ovary, the results of cross-breeding FSHKO
and AMHKO animals (Exp 3) clearly indicate that AMH is
a dominant regulator of early follicle growth. FSH does not
appear to be essential in preantral follicle growth because in
both AMHKO and FAKO females, less primordial and more
growing follicles were found. Indeed, even more growing
follicles are found in ovaries of FAKO females, probably as
a result of accumulation of these follicles because the absence
of FSH causes a block of follicular growth at the large pre-
antral/small antral follicle stage. It is known that FSH is not
necessary for preantral follicle growth, but because preantral
follicles are sensitive to FSH, one might expect that a com-
plete loss of FSH production in mice would lead to some
effects on preantral follicle growth. However, comparison of
the follicle population between wild-type and FSHKO fe-
males revealed that preantral follicle growth occurs to the
same extent in both genotypes. In addition, no effect was seen
in the absence of FSH on the primordial follicle pool. This is
in contrast to several studies in which the pool of primordial
and growing follicles was influenced by decreasing or in-
creasing gonadotropin levels, either by hypophysectomy in
adult mice or unilateral ovariectomy in aged rats (29, 30). The
only difference between these experimental animal models
and the model used in this study, the FSHKO mouse model,
is that in the present model, only FSH production is absent,
but in the other models both FSH and LH and/or other
hormones or growth factors are affected. In particular, it has
been shown that LH can stimulate primordial follicle re-
cruitment because in mice overexpressing LH increases the
outgrowth of primordial follicles (31). Until now, no data are
available about other factors from the pituitary gland, which
might exert an effect on recruitment of primordial follicles.
The question of by which mechanisms AMH inhibits the
stimulatory effect of FSH on follicle growth remains. Unlike
other members of the TGF superfamily, little is known
about the AMH signaling pathway. Members of this family
signal via complexes containing type I and II receptors. So far
only an AMH type II receptor has been identified (32). More
insight into the signaling pathway of AMH will be gained
after identification of the AMH type I receptor. Only recently
the activin receptor-like kinase 2 (33, 34) and 6 (35) have been
identified as candidate AMH type I receptors.
The inhibitory mechanism could involve an effect of AMH
on FSH receptor expression. A change in the expression of
the FSH receptor may change the sensitivity of a follicle to
FSH, as was demonstrated by studies in the bovine (8, 9).
However, several studies have shown that, besides FSH ef-
fects on the ovary, AMH can also inhibit similar effects in-
duced by cAMP, which is the second messenger of FSH (14,
36, 37). This would suggest that the molecular target site of
AMH action is downstream of the FSH receptor.
This study provides evidence for an inhibitory role of
AMH on FSH-stimulated preantral follicle growth. Regula-
tion of the sensitivity of large preantral follicles to FSH by
AMH could be important during cyclic recruitment because
FSH is a crucial regulator of this process. A possible role of
AMH in cyclic recruitment is indicated by the presence at
estrus of a group of nonatretic large preantral/small antral
follicles with high AMH mRNA expression and a group with
much lower AMH mRNA expression, whereas these follicles
were otherwise indistinguishable (38). The increased sensi-
tivity to FSH of the follicles with low AMH mRNA expres-
sion may allow these follicles to be selected for continued
growth and ovulation in the next estrous cycle. The inhibi-
tory action of AMH on growth stimulation by FSH can also
be relevant for small preantral follicles, even though these
follicles do not depend on FSH for their growth. Besides
FIG. 5. Follicle population in 4-month-old wild-type, AMHKO,
FSHKO, and FAKO female mice. A–D, Number of primordial folli-
cles (A), nonatretic small follicles (B), atretic small follicles (C), and
atretic oocytes (D). Data represent the mean  SEM (n  4). a, b, c, d,
Significant difference from wild-type, AMHKO, FSHKO, and FAKO
females, respectively (P  0.05). Note the difference in scale of the
y-axis among the different graphs.
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factors that stimulate preantral follicle growth, like FSH (3,
4), stem cell factor (39), and GDF9 (40), other inhibitory
factors, such as AMH, are important to make preantral fol-
licle growth a well-balanced process.
Taken altogether, ovarian follicle growth is under the in-
fluence of many growth regulatory factors, and from the
present study, it can be concluded that AMH is one of these
regulatory factors. Besides inhibiting the outgrowth of pri-
mordial follicles, AMH is also able to inhibit FSH-stimulated
follicle growth, by diminishing the sensitivity of the follicle
for FSH. Furthermore, AMH proves to be a more dominant
regulator of early follicle growth than FSH.
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